The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers-Reference-Cited by-同舟云学术

The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers

Published:2015-03-19 Issue:6 Volume:4 Page:e1009285
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Ujiie Hideki,Kadota Kyuichi,Nitadori Jun-ichi,Aerts Joachim G,Woo Kaitlin M,Sima Camelia S,Travis William D,Jones David R,Krug Lee M,Adusumilli Prasad S

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1009285

Reference44 articles.

1. Malignant mesothelioma

2. Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma

3. Induction Chemotherapy, Extrapleural Pneumonectomy, and Postoperative High-Dose Radiotherapy for Locally Advanced Malignant Pleural Mesothelioma: A Phase II Trial

4. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma

5. CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential expression of DMD transcripts as a novel prognostic biomarker in histologically diverse mesotheliomas;Translational Lung Cancer Research;2024-04

2. Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream;Frontiers in Immunology;2024-01-08

3. The Current Treatment Landscape of Malignant Pleural Mesothelioma and Future Directions;Cancers;2023-12-12

4. Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy;Cancers;2023-12-10

5. The Interplay Between the Immune System, Tumor Suppressor Genes, and Immune Senescence in Mesothelioma Development and Response to Immunotherapy;Journal of Thoracic Oncology;2023-11